A blood clue to a rare vessel disease?
NCT ID NCT03698071
First seen Aug 17, 2026 · Last updated Aug 17, 2026
Summary
This study looks at whether a protein in the blood, called soluble CD95 ligand, plays a role in ANCA-associated vasculitis, a rare group of diseases that cause inflammation of blood vessels. Researchers will collect blood and urine samples from 48 adults with the condition and track changes in the protein's levels over 12 months. The goal is to see if this marker could help with diagnosis, predicting disease activity, or finding new treatment approaches.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Blood and urine sample collection for biomarker analysis
- What this could lead to
- If the marker proves reliable, it could lead to a simple blood test to help diagnose or monitor ANCA-associated vasculitis, and possibly point toward new treatments.
- What could go wrong
- This is an observational study with a small number of participants, so the marker may not prove accurate or broadly applicable. It is exploratory and does not test any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANCA-ASSOCIATED VASCULITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Bordeaux - Service d'Immunologie et Immunogénétique
Bordeaux, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues in the blood may foretell heart trouble
- Can a new drug tame vasculitis with fewer side effects?
- Engineered immune cells take aim at autoimmune kidney diseases
- Could a diabetes drug shield kidneys from autoimmune attack?
- Scientists probe kidney cell metabolism to unlock secrets of ANCA vasculitis
- New tool could predict who will suffer from steroid side effects